Label: PINRID- pyrantel pamoate tablet

  • NDC Code(s): 73581-111-12, 73581-111-24
  • Packager: YYBA CORP
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated August 1, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active Ingredient (in each chewable tablet)

    Pyrantel pamoate 720.5 mg

    (equivalent to 250 mg pyrantel base)

  • Purpose

    Anthelmintic

  • Use

    for the treatment of pinworm infection

  • Warnings

    Keep out of reach of children. Do not exceed recommended dosage.

    If any of these conditions persist, consult a doctor

    • dizziness
    • diarhea
    • abdominal cramps
    • vomiting
    • nausea
    • headache

    In case of overdose, get medical help or contact a poison control center rightaway.

    If pregnant, breast-feeding, or if you have liver disease, ask a doctor before use. Contact your doctorif an allergic reaction occurs.

  • Directions

    • Important- treat the entire household
    • take only one dose unless directed by doctor
    • if signs of pinworms persist, see a doctor
    • do not repeat treatment unless directed by a doctor
    • less than 25 pounds (11 kg) or under 2 years old, consult a doctor
    • Consult your doctor before use
    25-37 lb½ tablet
    38-62 lbs1 tablets
    63-87 lbs1½ tablets
    88-112 lbs2 tablets
    113-137 lbs2½ tablets
    138-162 lbs3 tablets
    163-187 lbs3½ tablets
    over 188 lbs4 tablets

  • Other information:

    • Store at 15°-30°C (59° - 86 °F)
    • Protect from moisture and heat
  • Intactive ingredients

    bubble gum flavor, citric acid, D&C red#27, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid, sucralose.

  • Questions or comments:

    call toll free 1-866-933-6337

  • PRINCIPAL DISPLAY PANEL

    label-24

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    PINRID 
    pyrantel pamoate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73581-111
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PYRANTEL PAMOATE (UNII: 81BK194Z5M) (PYRANTEL - UNII:4QIH0N49E7) PYRANTEL250 mg
    Inactive Ingredients
    Ingredient NameStrength
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    D&C RED NO. 27 (UNII: 2LRS185U6K)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    Product Characteristics
    ColorpinkScore2 pieces
    ShapeROUNDSize16mm
    FlavorImprint Code PR1
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73581-111-1212 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2024
    2NDC:73581-111-2424 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02408/01/2024
    Labeler - YYBA CORP (006339772)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!